Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 26,500 shares at $1.51 ($40K) on 2023-03-22, disclosed to the SEC on 2023-03-24.
Open-market sale of $40k NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 2,122 | $3K | 8.5% |
| 2 | $1.51 | 11,667 | $18K | 44.0% |
| 3 | $1.50 | 12,711 | $19K | 47.6% |
| Total | $1.51 avg | 26,500 | $40K | 100% |
| Filing → |
| NMTC | SELL | 2026-03-16 | $734 | — | Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |